Patients with sleep apnea achieve similar outcomes when receiving care from a sleep specialist or nonspecialist
Obstructive sleep apnea (OSA) patients have similar outcomes regardless of sleep specialist or non-specialist care.
Care provided by NSSs and SSPs resulted in similar quality of life, adherence, and symptom scores (low-strength evidence), based on results from five randomized trials and three observational studies (1,515 participants; mean age, 52 years; 68% male).
The researchers found that LGB was associated with a greater drop in BMI. In intention-to-treat analyses, the effective apnea-hypopnea index (AHI) at nine months was 29.5 and 20 events/hour in the LGB and CPAP groups, respectively (P=0.02), while at 18 months, the effective AHI was 20.9 and 21.4 events/hour, respectively.
Understanding the powerful regulation of biology by circadian rhythms is beginning to lead to far-reaching changes in policy.
Overall among each medication type (prescription, over-the-counter and herbal/natural aids) 36% reported using some type of medication to aid their sleep.
Researchers from the Perelman School of Medicine at the University of Pennsylvania analyzed 66 studies to determine the antidepressant effects of sleep deprivation.
"The use of CPAP telemonitoring with automated feedback messaging improved 90-day adherence in OSA patients," the authors wrote.
When data was stratified for dogs who slept their pet-owner's bed and dogs who just slept in the room human sleep efficiency decreased to 80.1%±7.2%, while efficiency for the dog increased from 83.3%±19.8% to 85.4%±12.1% (P=0.003).
The results showed that as the week of 5 hours of sleep a night progressed, the participants increasingly started to choose the riskier option.
Significant differences were identified in PT seconds for the control group versus the moderate and severe OSA groups (mean, 11.26 versus 10.74 and 10.67, respectively).
"People who watched themselves gasping and struggling to breathe with sleep apnea used their CPAP machines three hours more per night than those who saw no video," said Mark Aloia, PhD, National Jewish Health in Denver.
"Immunomodulatory therapy should be considered early, because NSAIDs or a short course of oral corticosteroids may be sufficient for symptom remission in recent-onset cases, whereas those with long-standing symptoms often require more intensive and prolonged immunotherapeutic interventions," the authors write.
The researchers found an association between greater AD pathology and worse subjective sleep quality, more sleep problems, and daytime somnolence.
The researchers also saw evidence that lower melatonin levels correlated with lower 8-OH-dG. The 50 workers in the latest study were those who'd shown the biggest drop in melatonin during night work versus night sleep.
Researchers reviewed a total of 2,314 articles for zolpidem used to treat neurologic disorders across various databases.
The researchers found that 57.9% of all patients had impaired SQ in baseline evaluation. Obstructive apnea syndrome, snoring, and periodic leg movements were seen with PSG in 73.7, 74.4, and 26.3% of patients, respectively.
In this case, a 57-year-old Caucasian woman presented with hypersomnolence and altered mental status after having ingested 20-30 diphenhydramine 25mg tablets.
Researchers found the disrupted sleep pattern to be linked with cardiovascular disease, depression, fatigue, and daytime sleepiness.
"Expanded and pivotal clinical trials must still be conducted to fully establish the best approach to cannabinoid therapy in obstructive sleep apnea," said lead author Professor David Carley.
Significant overall improvements were also noted on the key secondary endpoint of improved Patient Global Impression of Change (PGIc) scale, with 90% of patients in the 150mg and 300mg arms reporting overall improvement at Week 12.
This lightweight skin-adhesive diagnostic patch is able to record nasal pressure, blood oxygen saturation, pulse, respiratory effort, sleep time, and body position.